+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 45Years
All Genders
ID07785934

Open-Label Study of UBT251 Injection Evaluating Drug Interactions with Metformin, Warfarin, Atorvastatin, and Digoxin in Adults with Overweight or Obesity

Led by The United Bio-Technology (Hengqin) Co., Ltd. · Updated on 2026-08-25

48

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the drug interaction potential of multiple-dose UBT251 Injection in adults with overweight or obesity aged 18 to 45 years. The study is an open-label Phase I trial involving two groups. Cohort 1 focuses on how UBT251 affects the pharmacokinetics of metformin and warfarin, while Cohort 2 studies its impact on atorvastatin and digoxin. The study also assesses safety and immune responses during treatment. Participants in Cohort 1 will first receive metformin and warfarin separately, followed by a 20-week dose-escalation phase of weekly UBT251 injections. Metformin and warfarin are then administered again after specific UBT251 doses to examine any interaction effects. Cohort 2 follows a similar plan with atorvastatin and digoxin given before and after the UBT251 dosing phase. All medications are administered orally except UBT251, given as a weekly subcutaneous injection. During the study, participants undergo blood sampling to measure drug levels and effects at defined times after doses. Researchers track pharmacokinetic and pharmacodynamic parameters, safety labs, vital signs, ECGs, and antibody development over about 190 days. The main outcome is the area under the plasma concentration-time curve for the studied drugs. Safety and tolerability are closely monitored throughout the trial period.

CONDITIONS

Brief Title

Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity

Research Team

W

Wei Hu, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here